These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 30382873)

  • 1. Identification of glioblastoma gene prognosis modules based on weighted gene co-expression network analysis.
    Xu P; Yang J; Liu J; Yang X; Liao J; Yuan F; Xu Y; Liu B; Chen Q
    BMC Med Genomics; 2018 Nov; 11(1):96. PubMed ID: 30382873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of co-expression modules related to survival by WGCNA and identification of potential prognostic biomarkers in glioblastoma.
    Zhou J; Guo H; Liu L; Hao S; Guo Z; Zhang F; Gao Y; Wang Z; Zhang W
    J Cell Mol Med; 2021 Feb; 25(3):1633-1644. PubMed ID: 33449451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A robust two-gene signature for glioblastoma survival prediction.
    Pan Y; Zhang JH; Zhao L; Guo JC; Wang S; Zhao Y; Tao S; Wang H; Zhu YB
    J Cell Biochem; 2020 Jul; 121(7):3593-3605. PubMed ID: 31960992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identify signature regulatory network for glioblastoma prognosis by integrative mRNA and miRNA co-expression analysis.
    Bing ZT; Yang GH; Xiong J; Guo L; Yang L
    IET Syst Biol; 2016 Dec; 10(6):244-251. PubMed ID: 27879479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 6-Gene Risk Signature Predicts Survival of Glioblastoma Multiforme.
    Zhao J; Wang L; Hu G; Wei B
    Biomed Res Int; 2019; 2019():1649423. PubMed ID: 31531345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between SNAP25 and human glioblastoma multiform: a comprehensive bioinformatic analysis.
    Yu C; Yin J; Wang X; Chen L; Wei Y; Lu C; You Y
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32412599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the potential biomarkers for prognosis of glioblastoma via weighted gene co-expression network analysis.
    Zhang M; Zhou Z; Liu Z; Liu F; Zhao C
    PeerJ; 2022; 10():e12768. PubMed ID: 35111402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large-Scale Analysis Reveals Gene Signature for Survival Prediction in Primary Glioblastoma.
    Prasad B; Tian Y; Li X
    Mol Neurobiol; 2020 Dec; 57(12):5235-5246. PubMed ID: 32875483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma.
    Huang QR; Li JW; Pan XB
    Medicine (Baltimore); 2021 Dec; 100(48):e28065. PubMed ID: 35049227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 63 signature genes prediction system is effective for glioblastoma prognosis.
    Zhang Y; Xu J; Zhu X
    Int J Mol Med; 2018 Apr; 41(4):2070-2078. PubMed ID: 29393370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of key genes involved in the recurrence of glioblastoma multiforme using weighted gene co-expression network analysis and differential expression analysis.
    Ren P; Wang J; Li L; Lin X; Wu G; Chen J; Zeng Z; Zhang H
    Bioengineered; 2021 Dec; 12(1):3188-3200. PubMed ID: 34238116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a Specific Gene Module for Predicting Prognosis in Glioblastoma Patients.
    Tang X; Xu P; Wang B; Luo J; Fu R; Huang K; Dai L; Lu J; Cao G; Peng H; Zhang L; Zhang Z; Chen Q
    Front Oncol; 2019; 9():812. PubMed ID: 31508371
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of key modules and hub genes in glioblastoma multiforme based on co-expression network analysis.
    Li C; Pu B; Gu L; Zhang M; Shen H; Yuan Y; Liao L
    FEBS Open Bio; 2021 Mar; 11(3):833-850. PubMed ID: 33423377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatics and machine learning methodologies to identify the effects of central nervous system disorders on glioblastoma progression.
    Rahman MH; Rana HK; Peng S; Hu X; Chen C; Quinn JMW; Moni MA
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33406529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDC6 is up-regulated and a poor prognostic signature in glioblastoma multiforme.
    Zhao H; Zhou X; Yuan G; Hou Z; Sun H; Zhai N; Huang B; Li X
    Clin Transl Oncol; 2021 Mar; 23(3):565-571. PubMed ID: 32661826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quiescent stem cell marker genes in glioma gene networks are sufficient to distinguish between normal and glioblastoma (GBM) samples.
    Mukherjee S
    Sci Rep; 2020 Jul; 10(1):10937. PubMed ID: 32616845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a key glioblastoma candidate gene, FUBP3, based on weighted gene co-expression network analysis.
    Li J; Zhang Z; Guo K; Wu S; Guo C; Zhang X; Wang Z
    BMC Neurol; 2022 Apr; 22(1):139. PubMed ID: 35413821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of
    Lin H; Yang Y; Hou C; Zheng J; Lv G; Mao R; Xu P; Chen S; Zhou Y; Wang P; Zhou D
    Genet Test Mol Biomarkers; 2021 May; 25(5):334-345. PubMed ID: 33970702
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of a long noncoding RNA signature to predict outcomes of glioblastoma.
    Li D; Lu J; Li H; Qi S; Yu L
    Mol Med Rep; 2019 Jun; 19(6):5406-5416. PubMed ID: 31059035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 4-gene panel predicting the survival of patients with glioblastoma.
    Guo XX; Su J; He XF
    J Cell Biochem; 2019 Sep; 120(9):16037-16043. PubMed ID: 31081973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.